Drug intelligence / Profile preview

Oniro

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Oniro is a dietary supplement derived from steamed onion, studied for its potential effects on body fat reduction and metabolic health. In a randomized clinical trial, ONIRO supplementation was shown to significantly reduce total body fat, particularly abdominal visceral fat, and improve clinically relevant metabolic parameters such as serum triglycerides and C-peptide levels in overweight individuals. The mechanism of action is not fully elucidated but is presumed to be related to bioactive compounds present in onions that may influence lipid metabolism and adiposity[7].

Beyond the preview

Go deeper on Oniro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oniro.

Explore the full profile